NTRK1 and nonpapillary renal cell carcinoma: In addition, because pAMPK inhibits HIF-α activity and HIF-α stably upregulates vascular endothelial growth factor in ccRCC [2,25], the association between pAMPK expression and vascular endothelial growth factor receptor tyrosine kinase inhibitors might be worth investigating.